文献速递主动脉疾病颈动脉与弓上血管

凹形三分支覆膜支架系统治疗主动脉弓病变:首例人体前瞻性队列研究

Concave Triple Branched Stent Graft System for Aortic Arch Pathologies: A First in Man Prospective Cohort Study.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2025-06-16

OBJECTIVE: Endovascular aortic arch repair with supra-aortic trunk (SAT) reconstruction is an alternative to open surgical replacement, but the ideal stent graft is still under investigation.…

要点

  • CS系统治疗主动脉弓病变技术成功率高,院内死亡率和卒中率均为0%。
  • 随访期间无死亡、卒中、逆行A型主动脉夹层、再干预或显著内漏。
  • 3例左颈总动脉出现轻中度支架内狭窄,需密切监测重建的弓上分支。

核心结论

  • CS系统用于主动脉弓病变腔内治疗在本研究中显示出有前景的安全性和有效性,一年随访期间无死亡、卒中、逆行A型主动脉夹层、再干预或显著内漏。
  • 应密切监测重建的弓上分支的狭窄情况。

研究设计与样本

  • 前瞻性队列研究,在三家医院开展,2022年3月至2023年6月入组患者。
  • 术前由跨学科委员会评估患者,所有患者均使用CS系统覆盖主动脉弓病变并重建全部弓上分支。
  • 随访在2周、6个月和12个月时进行CT扫描。

主要发现

  • 平均手术时间为160 ± 23分钟,平均透视时间为63 ± 20分钟。
  • 院内死亡率和卒中率均为0%,平均随访时间为456.9 ± 93.6天。
  • CS系统完全覆盖主动脉病变,所有重建分支保持通畅;单例内漏在6个月内自行封闭;3例左颈总动脉观察到轻中度支架内狭窄;无需二次干预。

临床怎么用

  • 对于主动脉弓病变,CS系统可作为开放手术替代的腔内治疗选择,在本研究中技术成功率高且无院内死亡和卒中。
  • 术后需通过CT随访密切监测重建的弓上分支,尤其是左颈总动脉的支架内狭窄情况。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Endovascular aortic arch repair with supra-aortic trunk (SAT) reconstruction is an alternative to open surgical replacement, but the ideal stent graft is still under investigation. This study describes the first experience and one year results of a novel, off the shelf, concave supra-arch triple branched stent graft system (CS system) for aortic arch diseases. METHODS: This was a prospective cohort study conducted in three hospitals, enrolling patients from March 2022 to June 2023, to evaluate use of the CS system for aortic arch pathologies. An interdisciplinary board assessed patients pre-operatively. All patients were treated using the CS system to cover the aortic arch pathologies and reconstruct all SATs. Follow up assessments were conducted with computed tomography scans at two weeks and six and 12 months. RESULTS: Ten patients (eight men) were treated using the CS system. The mean age was 65.3 years. Conditions included thoracic aortic aneurysm, non-A non-B aortic dissection, and penetrating aortic arch ulcer. Technical success was achieved in all patients, with one type III endoleak during the procedure. The mean procedure time was 160 ± 23 minutes and the mean fluoroscopy time was 63 ± 20 minutes. The in hospital mortality and stroke rates were both 0%. The mean follow up duration was 456.9 ± 93.6 days. All patients recovered well without complications. The CS system completely covered the aortic pathologies, and all reconstructed branches remained patent. The single endoleak sealed spontaneously within six months. Mild to moderate in stent stenosis was observed in three left common carotid arteries. No other morphological abnormalities were observed, and secondary interventions were not necessary. CONCLUSION: The CS system for endovascular treatment of aortic arch pathologies demonstrated promising safety and efficacy in this study, with no deaths, strokes, retrograde type A aortic dissections, re-interventions, or significant endoleaks during one year follow up. Stenosis of the reconstructed SATs should be monitored closely.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Shu C, Wang T, Fang K, et al. Concave Triple Branched Stent Graft System for Aortic Arch Pathologies: A First in Man Prospective Cohort Study. Eur J Vasc Endovasc Surg. 2025. PMID: 40516809. doi:10.1016/j.ejvs.2025.06.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。